Chemed Raises Full-Year EPS Guidance and Executes Substantial Share Repurchase
CHE sits 16% above its 52-week low of $365.205.
Summary
Chemed reported Q1 results, officially raised its full-year adjusted EPS guidance, and executed a significant $197.7 million share repurchase, signaling strong operational performance and capital allocation.
Key Events · Earnings and Guidance · CHE
-
Raised Full-Year EPS Guidance
Chemed increased its full-year 2026 adjusted diluted EPS guidance to a revised range of $24.00 to $24.75, up from the original $23.25 to $24.25, primarily driven by strong VITAS performance.
-
Significant Share Repurchase
The company repurchased 500,000 shares of its stock for $197.7 million during the first quarter, with approximately $229.6 million remaining under its existing share repurchase authorization.
-
Strong VITAS Performance
The VITAS Healthcare segment reported a 3.1% increase in net patient revenue to $420.0 million and a 6.9% increase in admissions, leading to an upward revision in its full-year ADC and revenue growth outlook.
-
Strategic Roto-Rooter Acquisitions
Roto-Rooter acquired two franchises for an aggregated $20.6 million, which are anticipated to add $5.0 million to $5.5 million in revenue for the remainder of 2026.
Analysis · CHE · Industrial Applications And Services
This 8-K details Chemed's first-quarter results, which include strong performance from its VITAS segment and a significant share repurchase. While the Q1 results were previously reported by news, the company has now officially raised its full-year adjusted EPS guidance, reflecting an improved operational outlook, particularly for VITAS. The substantial share repurchase demonstrates management's confidence and commitment to shareholder value, making this a notable capital allocation event.
At the time of this filing, CHE was trading at $422.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $365.21 to $593.81. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.